CO[C@](C(=O)OC[C@H]1[C@@H](COC(C)=O)[C@@H]2O[C@H]1c1cc3c(cc12)OCO3)(c1ccccc1)C(F)(F)F
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?